LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication

BACKGROUND: Triple negative breast cancer (TNBC) is a subtype of breast cancer with poor prognosis and lack of effective treatment target. Here we screened differentially expressed lncRNAs through bioinformatics analysis and identified CARMN as a downregulated lncRNA which is lowest expressed in TNB...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Xiaonan, Dai, Huijuan, Du, Yueyao, Peng, Jing, Sha, Rui, Yang, Fan, Zhou, Liheng, Lin, Yanping, Xu, Shuguang, Wu, Yifan, Yin, Wenjin, Lu, Jinsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220716/
https://www.ncbi.nlm.nih.gov/pubmed/34162418
http://dx.doi.org/10.1186/s13046-021-02015-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220716/
https://www.ncbi.nlm.nih.gov/pubmed/34162418
http://dx.doi.org/10.1186/s13046-021-02015-4

Ejemplares similares